Scarless excision of an insertion sequence restores capsule production and virulence in Acinetobacter baumannii.


Journal

The ISME journal
ISSN: 1751-7370
Titre abrégé: ISME J
Pays: England
ID NLM: 101301086

Informations de publication

Date de publication:
05 2022
Historique:
received: 31 08 2021
accepted: 16 12 2021
revised: 07 12 2021
pubmed: 25 12 2021
medline: 28 4 2022
entrez: 24 12 2021
Statut: ppublish

Résumé

We identify a new mechanism mediating capsule production and virulence in the WHO and CDC priority ESKAPE pathogen Acinetobacter baumannii. Non-capsulated and avirulent bacteria can revert into a capsulated and virulent state upon scarless excision of an ISAba13 insertion sequence under stress conditions. Reversion events fully restore capsule production and in vivo virulence. This increases our knowledge about A. baumannii genome dynamics, and the regulation of capsule production, virulence and resistance.

Identifiants

pubmed: 34949784
doi: 10.1038/s41396-021-01179-3
pii: 10.1038/s41396-021-01179-3
pmc: PMC9038732
doi:

Substances chimiques

DNA Transposable Elements 0
Virulence Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1473-1477

Informations de copyright

© 2022. The Author(s).

Références

Weinberg SE, Villedieu A, Bagdasarian N, Karah N, Teare L, Elamin WF. Control and management of multidrug resistant Acinetobacter baumannii: a review of the evidence and proposal of novel approaches. Infect Prev Pr. 2020;2:100077.
Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197:1079–81.
doi: 10.1086/533452
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18:318–27.
doi: 10.1016/S1473-3099(17)30753-3
US Department of Health and Human Services, CDC. Antibiotic resistance threats in the United States. Centers Dis Control Prev. 2019:1–113.
Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol. 2018;16:91–102.
doi: 10.1038/nrmicro.2017.148
Geisinger E, Huo W, Hernandez-Bird J, Isberg RR. Acinetobacter baumannii: envelope determinants that control drug resistance, virulence, and surface variability. Annu Rev Microbiol. 2019;73:481–506.
doi: 10.1146/annurev-micro-020518-115714
Wyres KL, Cahill SM, Holt KE, Hall RM, Kenyon JJ. Identification of Acinetobacter baumannii loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with kaptive. Microb Genomics. 2020;6:e000339.
Singh JK, Adams FG, Brown MH. Diversity and function of capsular polysaccharide in Acinetobacter baumannii. Front Microbiol. 2019;10:1–8.
Tipton KA, Rather PN. An omp-RenvZ two-component system ortholog regulates phase variation, osmotic tolerance, motility, and virulence in Acinetobacter baumannii strain AB5075. J Bacteriol. 2017;199:1–16.
doi: 10.1128/JB.00705-16
Chin CY, Tipton KA, Farokhyfar M, Burd EM, Weiss DS, Rather PN. A high-frequency phenotypic switch links bacterial virulence and environmental survival in Acinetobacter baumannii. Nat Microbiol. 2018;3:563–9.
doi: 10.1038/s41564-018-0151-5
Anderson SE, Chin CY, Weiss DS, Rather PN. Copy number of an integron-encoded antibiotic resistance locus regulates a virulence and opacity switch in Acinetobacter baumannii AB5075. mBio. 2020;11:1–19.
doi: 10.1128/mBio.02338-20
Ahmad I, Karah N, Nadeem A, Wai SN, Uhlin BE. Analysis of colony phase variation switch in Acinetobacter baumannii clinical isolates. PLoS ONE. 2019;14:1–13.
doi: 10.1371/journal.pone.0210082
Jacobs AC, Thompson MG, Black CC, Kessler JL, Clark LP, McQueary CN, et al. AB5075, a highly virulent isolate of Acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. mBio. 2014;5:1–10.
doi: 10.1128/mBio.01076-14
Geisinger E, Isberg RR. Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii. PLoS Pathog. 2015;11:1–27.
doi: 10.1371/journal.ppat.1004691
Ardissone S, Fumeaux C, Bergé M, Beaussart A, Théraulaz L, Radhakrishnan SK, et al. Cell cycle constraints on capsulation and bacteriophage susceptibility. eLife. 2014;3:1–30.
doi: 10.7554/eLife.03587
Kon H, Schwartz D, Temkin E, Carmeli Y, Lellouche J. Rapid identification of capsulated Acinetobacter baumannii using a density-dependent gradient test. BMC Microbiol. 2020;20:1–11.
doi: 10.1186/s12866-020-01971-9
Godeux AS, Lupo A, Haenni M, Guette-Marquet S, Wilharm G, Maria-Halima Laaberki XC. Fluorescence-Based Detection of Natural Transformation in Drug-Resistant Acinetobacter baumannii. 2018;200:e00181–18.
Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC, Mylonakis E. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother. 2009;53:2605–9.
doi: 10.1128/AAC.01533-08
Wen Z, Zhang JR. Bacterial capsules. Molecular Medical Microbiology: Second Edition. 2014. Elsevier Ltd.
Henderson IR, Owen P, James P. MicroReview Mol switches - Bact phase Var. 1999;33:919–32.
Chakravarty B. Genetic mechanisms of antibiotic resistance and virulence in Acinetobacter baumannii: background, challenges and future prospects. Mol Biol Rep. 2020;47:4037–46.
Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014;5:1–18.
doi: 10.3389/fmicb.2014.00643
Penesyan A, Nagy SS, Kjelleberg S, Gillings MR, Paulsen IT. Rapid microevolution of biofilm cells in response to antibiotics. npj Biofilms Microbiomes. 2019;5:34.
Gordillo Altamirano F, Forsyth JH, Patwa R, Kostoulias X, Trim M, Subedi D, et al. Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials. Nat Microbiol. 2021;6:157–61.
doi: 10.1038/s41564-020-00830-7
Hammerschmidt S, Hilse R, Van Putten JPM, Gerardy-Schahn R, Unkmeir A, Frosch M. Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J. 1996;15:192–8.
doi: 10.1002/j.1460-2075.1996.tb00347.x
Adams MD, Bishop B, Wright MS. Quantitative assessment of insertion sequence impact on bacterial genome architecture. Microb Genomics. 2016;2:e000062.
Gallagher LA, Ramage E, Weiss EJ, Radey M, Hayden HS, Held KG, et al. Resources for genetic and genomic analysis of emerging pathogen Acinetobacter baumannii. J Bacteriol. 2015;197:2027–35.
doi: 10.1128/JB.00131-15
Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–20.
doi: 10.1093/bioinformatics/btu170
Holley G, Beyter D, Ingimundardottir H, Møller PL, Kristmundsdottir S, Eggertsson HP, et al. Ratatosk: hybrid error correction of long reads enables accurate variant calling and assembly. Genome Biol. 2021;22:1–22.
doi: 10.1186/s13059-020-02244-4
Kolmogorov M, Yuan J, Lin Y, Pevzner PA. Assembly of long, error-prone reads using repeat graphs. Nat Biotechnol. 2019;37:540–6.
doi: 10.1038/s41587-019-0072-8
Walker BJ, Abeel T, Shea T, Priest M, Abouelliel A, Sakthikumar S, et al. Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS ONE. 2014;9. https://doi.org/10.1371/journal.pone.0112963 .
Wyres KL, Wick RR, Gorrie C, Jenney A, Follador R, Thomson NR, et al. Identification of Klebsiella capsule synthesis loci from whole genome data. Micro Genomics. 2016;2:e000102.
Sullivan MJ, Petty NK, Beatson SA. Easyfig: a genome comparison visualizer. Bioinformatics. 2011;27:1009–10.
doi: 10.1093/bioinformatics/btr039
Kumar A, Dalton C, Cortez-Cordova J, Schweizer HP. Mini-Tn7 vectors as genetic tools for single copy gene cloning in Acinetobacter baumannii. J Microbiol Methods. 2010;82:296–300.
doi: 10.1016/j.mimet.2010.07.002
Wilharm G, Piesker J, Laue M, Skiebe E. DNA uptake by the nosocomial pathogen Acinetobacter baumannii occurs during movement along wet surfaces. J Bacteriol. 2013;195:4146–53.
doi: 10.1128/JB.00754-13

Auteurs

Clémence Whiteway (C)

Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, Brussels, Belgium.
Structural Biology Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Adam Valcek (A)

Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, Brussels, Belgium.
Structural Biology Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Chantal Philippe (C)

Research Unit in the Biology of Microorganisms (URBM), NARILIS, University of Namur (UNamur), Namur, Belgium.

Mojca Strazisar (M)

Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.

Tim De Pooter (T)

Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.

Ivan Mateus (I)

Department of Ecology and Evolution, University of Lausanne, Lausanne, Switzerland.

Anke Breine (A)

Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, Brussels, Belgium.
Structural Biology Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Charles Van der Henst (C)

Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, Brussels, Belgium. charles.vanderhenst@vub.vib.be.
Structural Biology Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium. charles.vanderhenst@vub.vib.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH